KD Logo

Health Catalyst Inc [HCAT] stock was sold by Freeman Kevin Lee at the price of US$67073.0

In a filing, Health Catalyst Inc revealed its Chief Commercial Officer Freeman Kevin Lee unloaded Company’s shares for reported $67073.0 on Dec 02 ’24. In the deal valued at $8.94 per share,7,500 shares were sold. As a result of this transaction, Freeman Kevin Lee now holds 236,950 shares worth roughly $1.88 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Linda Llewelyn bought 7,766 shares, generating $69,661 in total proceeds.

Before that, Benjamin Landry Officer bought 9,419 shares. Health Catalyst Inc shares valued at $84,488 were divested by the Officer at a price of $8.97 per share.

KeyBanc Capital Markets downgraded its Health Catalyst Inc [HCAT] rating to a Sector weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Evercore ISI’s analysts, who increased its forecast for the stock in early January from “an In-line” to “an Outperform”. Barclays began covering HCAT with “an Overweight” recommendation on January 03, 2024. JP Morgan revised its rating on December 13, 2023. It rated HCAT as “an Overweight” which previously was an “a Neutral”.

Price Performance Review of HCAT

On Tuesday, Health Catalyst Inc [NASDAQ:HCAT] saw its stock fall -11.97% to $7.94. Over the last five days, the stock has lost -6.81%. Health Catalyst Inc shares have fallen nearly -14.25% since the year began. Nevertheless, the stocks have risen 4.34% over the past one year. While a 52-week high of $11.41 was reached on 01/12/24, a 52-week low of $5.42 was recorded on 08/07/24. SMA at 50 days reached $8.13, while 200 days put it at $7.31.

Levels Of Support And Resistance For HCAT Stock

The 24-hour chart illustrates a support level at 7.61, which if violated will result in even more drops to 7.28. On the upside, there is a resistance level at 8.59. A further resistance level may holdings at 9.24. The Relative Strength Index (RSI) on the 14-day chart is 46.77, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.42, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 63.73%. Stochastics %K at 72.70% indicates the stock is a holding.

How much short interest is there in Health Catalyst Inc?

A steep rise in short interest was recorded in Health Catalyst Inc stocks on 2024-11-15, dropping by 80513.0 shares to a total of 2.53 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 2.61 million shares. There was a decline of -3.18%, which implies that there is a negative sentiment for the stock.

Most Popular